Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2025-12-29 @ 12:37 PM
Study NCT ID:
NCT05509595
Status:
COMPLETED
Last Update Posted:
2025-01-22
First Post:
2022-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
Sponsor:
National Institute of Dental and Craniofacial Research (NIDCR)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
10000798
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None